Edge AI in Healthcare

When Innovation Meets Reality: How the Mayo Clinic–ASU Alliance Is Redefining Healthcare Technology

The healthcare technology sector has no shortage of brilliant ideas. What it has historically lacked is a reliable bridge between a promising pilot and meaningful, scalable care delivery. Collaborating with the Mayo Clinic and Arizona State University (ASU) Health Care Accelerator has reinforced why that bridge matters and why this extraordinary partnership stands out as one of the most compelling models I’ve encountered.

The Problem No One Was Solving

When I first engaged in the program, Dr. Steven Lester, the Accelerator’s co-founder and Chief Medical Officer, articulated a challenge I immediately recognized from the technology side: exceptional healthcare innovations were emerging, yet too often failing to translate into real-world clinical impact. The issue wasn’t a lack of creativity; it was the absence of true clinical integration, validation, and trust.

Too many solutions were built around healthcare rather than within it. Founders frequently underestimated the complexity of clinical workflows, regulatory pathways, reimbursement models, and the day‑to‑day realities of patient care. A technology might shine in a controlled pilot, only to falter when introduced into the variability of a large health system operating on razor‑thin margins. I’ve seen this pattern across industries, but in healthcare, both the stakes and the complexity are uniquely high.

That insight became the foundation for a program intentionally designed to shift healthcare innovation from a push model to a pull model creating solutions that clinicians and health systems actively want because they are built with them, not just for them.

Why the ASU Partnership Is Central to the Model

ASU plays a critical role in the Mayo Clinic and ASU Health Care Accelerator, contributing capabilities that are foundational to how the model operates. ASU brings an expansive academic infrastructure that dramatically widens the intellectual and research resources available to every startup in the program.

When the accelerator evaluates a company, it draws simultaneously on two powerful institutional ecosystems: Mayo Clinic’s more than 85,000 employees and deep clinical expertise, and ASU’s broad academic and research capabilities. Together, they map each startup to the right clinical environment, the right subject matter experts, and the right research pathways from the outset.

“As Dr. Barbara Marusiak, Co‑Director of the Mayo Clinic and ASU Health Care Accelerator, explains:

“What ASU brings to this model is the ability to translate innovation into something that can actually function in a clinical environment. It’s not just access to expertise; it’s access to the full continuum from research to regulatory strategy to workforce readiness. The combination of Mayo Clinic and ASU allows us to evaluate not just whether a solution works, but whether it can work consistently, safely, and at scale. That’s what allows these companies to move beyond concept and into real-world care delivery”

This dual‑institution foundation is not incidental, it is the engine of the model. ASU’s academic depth enables access to innovative research, interdisciplinary collaboration, and sustained knowledge co‑development that no single health system could provide alone. The result is a more rigorous and realistic preparation for healthcare deployment, helping technically strong solutions mature into offerings that are clinically indispensable.

Friction Testing Before the Market Does

One of the most distinctive features of the program is what Dr. Lester calls "friction testing." Rather than allowing companies to stay in a pilot mindset, the accelerator pushes founders to ask harder questions from day one: Will this solution work here? Will it work every day? Will it work for every patient? And will it work at scale?

Startups are immersed in real clinical workflows within Mayo Clinic, one of the most sophisticated and demanding care delivery environments in the world. This process has helped founders pivot from impressive demos to solutions aligned with reimbursement realities, workflow constraints, and what Dr. Lester calls the "triple win": increased patient access, enhanced patient and provider satisfaction, and a favorable impact on health system margins. Watching alumni companies return to later cohort ceremonies, some two and three years on, to share how far they've come is genuinely inspiring. It validates everything we're trying to build together.

Edge Computing: Where Clinical AI Meets Care Delivery

From Intel’s perspective, one challenge early‑stage health tech companies consistently underestimate is deployment architecture. Cloud infrastructure is essential and remains foundational in healthcare, enabling scalability, aggregation, and system‑level intelligence. Yet many solutions default to cloud‑centric models without fully accounting for the latency, cost, and workflow constraints that emerge at scale.

Healthcare is among the largest and fastest‑growing sources of data globally, but much of that data is still not leveraged where it matters most at the point of care. The opportunity, and the responsibility, is not to displace centralized infrastructure, but to augment it by bringing intelligence closer to where data is created and clinical decisions are made.

This is where hybrid edge‑to‑cloud architectures become critical. When AI capabilities are distributed across the cloud, the enterprise edge, and endpoints within care settings at the bedside, in the imaging suite, and, where appropriate, in the home, intelligence becomes context‑aware and immediately actionable. It moves from being something clinicians must actively seek out to something embedded directly into existing workflows.

Dr. Steven Lester, a cardiologist, captured this reality succinctly: he makes thousands of clicks each day, and every added moment of friction increases the risk of non‑adoption. Intel’s AI PC architecture—combining CPU, integrated graphics, and a neural processing unit (NPU) is designed to efficiently distribute these workloads on existing hospital infrastructure. This enables responsive, reliable AI at the edge while remaining tightly integrated with cloud systems, helping reduce complexity and support the transition from pilot environments to sustained clinical deployment.

Building an Ecosystem, Not Just Companies

Looking ahead, I believe success for this accelerator won't be measured in the number of companies supported. It will be measured in how many solutions become genuinely embedded in care delivery and in whether healthcare's default question shifts from "Can we pilot this?" to "How do we deploy this at scale responsibly and quickly?"

That kind of cultural shift requires more than any single institution. It requires the layered ecosystem that the Mayo Clinic and ASU Health Care Accelerator has intentionally built world-class clinical rigor, deep academic research capacity from ASU, sustained technology partnership from industry, and a growing network of startups shaped by all three. Intel is proud to be a sustained partner in this work, not as a one-time sponsor, but as a member of the ecosystem that makes scalable healthcare innovation possible.

This kind of innovation doesn’t happen in isolation. It takes an ecosystem built for translation, trust, and scale—and the Mayo Clinic and ASU Health Care Accelerator is setting that standard.

Want to go deeper on how the Mayo Clinic and ASU Health Care Accelerator is transforming healthcare innovation and why edge computing is the missing piece for AI at scale? Listen to the full podcast on the HIMSS platform and discover how ecosystem collaboration, clinical immersion, and purpose-built technology are turning promising pilots into embedded, scalable care solutions.

Alex Flores is General Manager of Health and Life Sciences at Intel and an industry partner of the Mayo Clinic and ASU Alliance for Health Care Accelerator.